scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VETIMM.2014.05.001 |
P698 | PubMed publication ID | 24880702 |
P2093 | author name string | Hirokazu Hikono | |
Takehiko Saito | |||
Ryota Tsunekuni | |||
P2860 | cites work | Classification of avian paramyxoviruses by immunodiffusion on the basis of antigenic specificity of their M protein antigens. | Q45979013 |
Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa--implications for diagnosis and control | Q46050321 | ||
Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease | Q47858116 | ||
Natural and experimental infection of turkeys with avian paramyxovirus-7 | Q57109224 | ||
Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests | Q68965252 | ||
Serological survey on prevalence of antibodies to avian paramyxovirus serotype 2 in China | Q80222338 | ||
Pathogenicity of PMV-3/parakeet/Netherlands/449/75 for chickens | Q81927567 | ||
Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease | Q84930135 | ||
Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. | Q30357521 | ||
Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland Islands | Q30496940 | ||
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses | Q33490614 | ||
Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome | Q33533355 | ||
Recombinant Newcastle disease virus as a vaccine vector | Q33850246 | ||
Retracted: Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1-9 in Chickens and Ducks | Q34256243 | ||
Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens | Q35077454 | ||
Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). | Q35790333 | ||
Pathogenesis of Two Strains of Avian Paramyxovirus Serotype 2, Yucaipa and Bangor, in Chickens and Turkeys | Q36190536 | ||
Development of nonhuman adenoviruses as vaccine vectors | Q36317264 | ||
The use of vaccination as an option for the control of avian influenza | Q36856576 | ||
A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. | Q37492711 | ||
Detection of paramyxoviruses in Magellanic penguins (Spheniscus magellanicus) on the Brazilian tropical coast. | Q39008492 | ||
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). | Q39897024 | ||
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals | Q40828974 | ||
Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase | Q41441113 | ||
Complete genome sequence of a novel avian paramyxovirus | Q41904651 | ||
Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12). | Q44166693 | ||
Effect of paramyxovirus yucaipa on fertility, hatchability, and poult yield of turkeys. | Q44789204 | ||
Prevalence of antibodies to different avian paramyxoviruses in commercial poultry in the United States | Q45163873 | ||
Detection and isolation of exotic Newcastle disease virus from field-collected flies | Q45399834 | ||
Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes | Q45723618 | ||
Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. | Q45749425 | ||
Evaluation of Different Methods of Inactivation of Newcastle Disease Virus and Avian Influenza Virus in Egg Fluids and Serum | Q45856223 | ||
P433 | issue | 3-4 | |
P921 | main subject | Newcastle disease virus | Q327082 |
immunization | Q1415366 | ||
vector-borne disease | Q2083837 | ||
Newcastle disease | Q11903425 | ||
P304 | page(s) | 184-191 | |
P577 | publication date | 2014-05-14 | |
P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
P1476 | title | Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus | |
P478 | volume | 160 |
Q40362937 | A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus |
Q58800131 | Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives |
Q91258218 | Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions |
Q47604109 | Next-generation sequencing of five new avian paramyxoviruses 8 isolates from Kazakhstan indicates a low genetic evolution rate over four decades. |
Search more.